The BOPA Advanced Pharmacist Training Day June 2025 – deadline for registration extended to 15th June!

Overview This study day is intended to provide an overview of the knowledge, skills, experiences and behaviours required to practice at an advanced level in Cancer Care. The study day will focus on the following areas:

  1. Consultant pharmacist / Advance Clinical Practitioner pathway
  2. Setting up a Non-Medical Prescriber clinic
  3. Research pillar of advanced practice
  4. Maintaining mental health and wellbeing

Intended audience Band 7 oncology and haematology trained pharmacists with greater or equal to 5 years of clinical experience and Band 8a oncology and haematology trained pharmacists.

  • WHEN: Wednesday 18th June 2025, 9am – 4:30pm
  • WHERE: Radisson Blu Hotel, 12 Holloway Circus, St. Chads Tunnel, Birmingham, B1 1BT (0.2 miles (4 minute walk) from Birmingham New Street Station).
  • COST: A non-refundable payment of £25.00.

This event is sponsored by Lilly Pharmaceuticals and run by BOPA Education and Training Subcommittee

Registration Details – Via Link below. Please note – only register if you can definitely make this course.  More event details and itinerary can be found here:https://www.bopa.org.uk/event/the-bopa-advanced-pharmacist-training-day/

Deadline date for registration has been extended to 15th June 2025

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article